Anti-LARS Antibody
Overview
This antibody is raised against a protein sequence from human LARS (leucyl-tRNA synthetase). It is supplied as part of the Atlas Antibodies Triple A Polyclonals portfolio and is intended for detection of endogenous LARS in human-derived samples. The manufacturer reports validation of this antibody for Western blot analysis.
Highlights
- Antibody targeting human leucyl-tRNA synthetase
- Validated application: Western blot (WB)
- Immunogen derived from a defined LARS protein sequence
- Supplied in a glycerol-containing phosphate buffer formulation
At-a-glance
- Target protein
- LARS (leucyl-tRNA synthetase)
- Alternative gene names
- FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS
- Host species
- Rabbit
- Clonality
- Polyclonal
- Validated applications
- Western blot (WB)
- Immunogen sequence
- KWDTERVFEVNASNLEKQTSKGKYFVTFPYPYMNGRLHLGHTFSLSKCEFAVGYQRLKGKCCLFPFGLHCTGMPIKACADKLK
- Buffer composition
- 40% glycerol, PBS (pH 7.2), 0.02% sodium azide
- Condition
- New / Unused — The product is only validated for WB application
Applications
This antibody is suitable for Western blot detection of LARS in human-derived samples. It may be used in research examining aminoacyl-tRNA synthetases and protein translation mechanisms. Validation is not reported for applications beyond Western blot.
Sustainability
By rehoming surplus lab products, this listing supports waste reduction and resource efficiency.
